Viewing Study NCT02525133

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-03-08 @ 4:12 AM
Study NCT ID: NCT02525133
Status: COMPLETED
Last Update Posted: 2021-01-08
First Post: 2015-08-12
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
Sponsor: Innocoll
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain, Postoperative View
Keywords:

Keywords

Keyword Brief Keyword Text View
None post operative pain View
None hernioplasty View
None bupivacaine View